Αρχική World News Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy... World News Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy Among Adult Patients with Ph-positive ALL Από Ogkologos - 16 Οκτωβρίου, 2026 233 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the GIMEMA ALL2820 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR A Large Case-Control Study of Hodgkin Lymphoma Survivors Suggests a Dose-Response... 16 Φεβρουαρίου, 2023 How to Provide Support as a Long-Distance Cancer Caregiver 25 Ιανουαρίου, 2021 FDA Approves Zanubrutinib for Waldenström’s Macroglobulinemia 3 Σεπτεμβρίου, 2021 6 Things to Know About Regrowing and Caring for Your Hair... 8 Ιανουαρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Exposure to Antibiotics, Specifically Fluoroquinolones, Before Treatment with Immune Checkpoint Inhibitor... EMA Recommends Granting a Marketing Authorisation for Asciminib EMA Recommends Granting a Marketing Authorisation for Nirogacestat EMA Recommends Extension of Therapeutic Indications for Epcoritamab
